Business Description
BioStem Technologies Inc
NAICS : 325411
SIC : 2834
ISIN : US0906842002
Description
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AmnioWrap2.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -0.61 | |||||
| Debt-to-Equity | -1.71 | |||||
| Debt-to-EBITDA | -1.37 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -5.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 28.5 | |||||
| 3-Year EBITDA Growth Rate | 0.9 | |||||
| 3-Year EPS without NRI Growth Rate | 12.6 | |||||
| 3-Year FCF Growth Rate | -20.4 | |||||
| 3-Year Book Growth Rate | 8.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.98 | |||||
| 9-Day RSI | 33.3 | |||||
| 14-Day RSI | 40.01 | |||||
| 6-1 Month Momentum % | 198.1 | |||||
| 12-1 Month Momentum % | 330.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.48 | |||||
| Quick Ratio | 0.42 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 300.4 | |||||
| Days Sales Outstanding | 74.47 | |||||
| Days Payable | 578.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.5 | |||||
| Shareholder Yield % | -0.61 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.27 | |||||
| Operating Margin % | -94.63 | |||||
| Net Margin % | -99.44 | |||||
| FCF Margin % | -16.69 | |||||
| ROA % | -119.71 | |||||
| ROIC % | -72.2 | |||||
| ROC (Joel Greenblatt) % | -302.3 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 25.16 | |||||
| EV-to-EBIT | -27.62 | |||||
| EV-to-EBITDA | -28.83 | |||||
| EV-to-Revenue | 25.56 | |||||
| EV-to-FCF | -158.05 | |||||
| Earnings Yield (Greenblatt) % | -3.62 | |||||
| FCF Yield % | -0.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BSEM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioStem Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4.968 | ||
| EPS (TTM) ($) | -0.41 | ||
| Beta | 0.17 | ||
| Volatility % | 91.07 | ||
| 14-Day RSI | 40.01 | ||
| 14-Day ATR ($) | 0.879223 | ||
| 20-Day SMA ($) | 12.00175 | ||
| 12-1 Month Momentum % | 330.73 | ||
| 52-Week Range ($) | 1.2 - 15.5 | ||
| Shares Outstanding (Mil) | 13.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioStem Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioStem Technologies Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioStem Technologies Inc Frequently Asked Questions
What is BioStem Technologies Inc(BSEM)'s stock price today?
The current price of BSEM is $9.36. The 52 week high of BSEM is $15.50 and 52 week low is $1.20.
When is next earnings date of BioStem Technologies Inc(BSEM)?
The next earnings date of BioStem Technologies Inc(BSEM) is .
Does BioStem Technologies Inc(BSEM) pay dividends? If so, how much?
BioStem Technologies Inc(BSEM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers